Status | Study |
Completed |
Study Name: Emergency Evaluation of Convalescent Plasma for Ebola Viral Disease (EVD) in Guinea Condition: Hemorrhagic Fever, Ebola Date: 2015-01-12 Interventions: Other: Convalescent Plasma Patients will be treated with plasma from recovered EVD patients. |
Completed |
Study Name: Phase I Trial to Assess the Safety, Tolerability and Immunogenicity of a Ebola Virus Vaccine (rVSVΔG-ZEBOV-GP) Condition: Hemorrhagic Fever, Ebola Date: 2014-10-31 Interventions: Biological: rVSVΔ-ZEBOV-GP single dose of rVSVΔ-ZEBOV-GP (3x10^6 pfu, 2x10^7 pfu or 3x10^5) |
Active, not recruiting |
Study Name: Phase 2a Immunogenicity Study of Hantaan/Puumala Virus DNA Vaccine for Prevention of Hemorrhagic Fever Condition: Hemorrhagic Fever With Renal Syndrome Date: 2014-04-14 Interventions: Biological: HTNV/PUUV DNA vaccine |
Completed |
Study Name: Activated Recombinant Human Factor VII in Patients With Dengue Haemorrhagic Fever Condition: Acquired Bleeding Disorder Dengue Haemorrhagic Fever Date: 2012-05-14 Interventions: Drug: activated recombinant human factor VII |
Withdrawn |
Study Name: A Study to Assess the Safety, Tolerability and Pharmacokinetics of AVI-7537 in Healthy Adult Volunteers Condition: Ebola Hemorrhagic Fever Date: 2012-05-03 Interventions: Drug: AVI-7537 |
Completed |
Study Name: A Study to Assess the Safety, Tolerability and Pharmacokinetics of AVI-7288 in Healthy Adult Volunteers Condition: Marburg Hemorrhagic Fever Date: 2012-03-27 Interventions: Drug: AVI-7288 |
Completed |
Study Name: Study to Evaluate the Safety, Tolerability, and Immunogenicity of Hantaan and Puumala Virus DNA Vaccines Condition: Hemorrhagic Fever With Renal Syndrome Date: 2011-12-23 Interventions: Biological: Vaccine/device combination for prevention of HFRS PUUV DNA Vaccine, 2.0mg/ml TDS-IM injectio |
Completed |
Study Name: Safety Study of Single Administration Post-Exposure Prophylaxis Treatment for Ebola Virus Condition: Ebola Hemorrhagic Fever Date: 2011-05-10 Interventions: Drug: Placebo Normal saline |
Completed |
Study Name: Safety Study of Single Administration Post-exposure Prophylaxis Treatment for Marburg Virus Condition: Marburg Hemorrhagic Fever Date: 2011-04-22 Interventions: Drug: AVI-6003 Single intraven |
Completed |
Study Name: Study of CYD Dengue Vaccine in Healthy Children and Adolescents in South America Condition: Dengue Dengue Hemorrhagic Fever Date: 2010-08-20 Interventions: Biological: Live, attenuated, recombinant dengue serotype 1 , 2, 3 , and 4 v |